MRNA

2025Q4BMO

Moderna Inc primary · HEALTHCARE · BIOTECHNOLOGY

Report 2026-02-13 · Fiscal end 2025-12-31 · Features as of 2026-02-12

← Earnings history

Pre-Earnings Data

Expectations & setup

Street

Consensus EPS-2.64
Consensus rev—
EPS high—
EPS low—
Dispersion—
Analysts—
EPS rev net 7d—
EPS rev net 30d—
Consensus Δ 7d—
Consensus Δ 30d—

Options

Implied move5.3%
IV front—
P/C full—
P/C front—
Features as of2026-02-12

Run-up

Close—
Ret 5d-1.9%
Ret 10d-14.4%
Ret 20d-1.2%
Ret 30d+31.9%

Post-Earnings Data

Results & reaction

Print

Actual EPS
-2.11Beat
Estimated EPS-2.64
Actual revenue
678.0M
Surprise %+20.1%
Beat / missBeat
Beat streak 44
Beat streak 84

Reaction

1-day stock reaction+0.9%
Implied vs actual

Implied 5.3%Actual 4.3%

Gap reaction+4.3%
Day result+5.3%
Next-day upYes
Realized / IV0.81×

Post tape

Post 5d+19.1%
Post 10d+25.1%
Post volume16.3M
Vol ×10d1.56×
Vol ×20d1.24×
Post range8.6%